| 摘要 |
<p>Described herein are compounds of formula (I) or pharmaceutical acceptable salts or solvates thereof, wherein G1, L1, R2, R3, n, p, Ar1, and Ar2 are defined in the description. Methods of making said compounds, and compositions comprising said compounds which are useful for inhibiting kinases such as IGF-IR are also disclosed.</p> |
| 申请人 |
ABBOTT LABORATORIES;CLARK, RICHARD, F.;BA-MAUNG, NWE, Y.;ERICKSON, SCOTT, A.;FIDANZE, STEVE, D.;MANTEI, ROBERT, A.;SHEPPARD, GEORGE, S.;SORENSEN, BRYAN, K.;WANG, GARY, T.;WANG, JIEYI;BELL, RANDY, L. |
发明人 |
CLARK, RICHARD, F.;BA-MAUNG, NWE, Y.;ERICKSON, SCOTT, A.;FIDANZE, STEVE, D.;MANTEI, ROBERT, A.;SHEPPARD, GEORGE, S.;SORENSEN, BRYAN, K.;WANG, GARY, T.;WANG, JIEYI;BELL, RANDY, L. |
